Pieris Pharmaceuticals Inc
NASDAQ:PIRS
Income Statement
Earnings Waterfall
Pieris Pharmaceuticals Inc
Revenue
|
42.8m
USD
|
Operating Expenses
|
-58.7m
USD
|
Operating Income
|
-15.8m
USD
|
Other Expenses
|
-8.7m
USD
|
Net Income
|
-24.5m
USD
|
Income Statement
Pieris Pharmaceuticals Inc
Dec-2014 | Mar-2015 | Jun-2015 | Sep-2015 | Dec-2015 | Mar-2016 | Jun-2016 | Sep-2016 | Dec-2016 | Mar-2017 | Jun-2017 | Sep-2017 | Dec-2017 | Mar-2018 | Jun-2018 | Sep-2018 | Dec-2018 | Mar-2019 | Jun-2019 | Sep-2019 | Dec-2019 | Mar-2020 | Jun-2020 | Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||||||||||||||||||||||||||||||
Revenue |
5
N/A
|
4
-21%
|
4
-13%
|
4
+11%
|
3
-28%
|
4
+35%
|
5
+23%
|
5
+8%
|
6
+11%
|
6
+2%
|
7
+13%
|
10
+47%
|
25
+157%
|
28
+11%
|
38
+35%
|
42
+12%
|
29
-31%
|
34
+15%
|
27
-19%
|
34
+25%
|
46
+36%
|
51
+10%
|
57
+12%
|
45
-21%
|
29
-34%
|
32
+8%
|
24
-25%
|
25
+5%
|
31
+26%
|
27
-15%
|
27
+2%
|
29
+5%
|
26
-9%
|
17
-35%
|
33
+97%
|
47
+43%
|
43
-10%
|
|
Operating Income | ||||||||||||||||||||||||||||||||||||||
Operating Expenses |
(13)
|
(14)
|
(15)
|
(17)
|
(17)
|
(18)
|
(21)
|
(24)
|
(29)
|
(32)
|
(35)
|
(37)
|
(40)
|
(43)
|
(47)
|
(54)
|
(60)
|
(67)
|
(71)
|
(72)
|
(73)
|
(71)
|
(70)
|
(68)
|
(63)
|
(67)
|
(71)
|
(78)
|
(83)
|
(81)
|
(77)
|
(71)
|
(69)
|
(62)
|
(65)
|
(69)
|
(59)
|
|
Selling, General & Administrative |
(7)
|
(9)
|
(8)
|
(9)
|
(8)
|
(8)
|
(8)
|
(8)
|
(9)
|
(11)
|
(13)
|
(13)
|
(18)
|
(18)
|
(18)
|
(20)
|
(18)
|
(19)
|
(18)
|
(19)
|
(18)
|
(18)
|
(18)
|
(18)
|
(17)
|
(16)
|
(16)
|
(16)
|
(17)
|
(17)
|
(17)
|
(17)
|
(16)
|
(16)
|
(16)
|
(19)
|
(17)
|
|
Research & Development |
(6)
|
(6)
|
(7)
|
(8)
|
(8)
|
(10)
|
(13)
|
(16)
|
(20)
|
(21)
|
(22)
|
(24)
|
(22)
|
(25)
|
(29)
|
(34)
|
(41)
|
(48)
|
(52)
|
(54)
|
(55)
|
(53)
|
(51)
|
(50)
|
(47)
|
(50)
|
(55)
|
(62)
|
(67)
|
(64)
|
(60)
|
(55)
|
(53)
|
(52)
|
(55)
|
(51)
|
(42)
|
|
Other Operating Expenses |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
6
|
5
|
0
|
0
|
|
Operating Income |
(7)
N/A
|
(10)
-42%
|
(11)
-7%
|
(13)
-19%
|
(14)
-5%
|
(14)
-5%
|
(17)
-16%
|
(19)
-14%
|
(23)
-20%
|
(26)
-16%
|
(28)
-8%
|
(27)
+4%
|
(15)
+47%
|
(15)
-1%
|
(9)
+38%
|
(12)
-29%
|
(31)
-164%
|
(33)
-8%
|
(43)
-30%
|
(38)
+11%
|
(27)
+29%
|
(20)
+25%
|
(13)
+37%
|
(23)
-79%
|
(34)
-48%
|
(35)
-4%
|
(47)
-34%
|
(53)
-13%
|
(52)
+3%
|
(54)
-5%
|
(50)
+8%
|
(43)
+14%
|
(43)
-1%
|
(45)
-5%
|
(32)
+29%
|
(22)
+32%
|
(16)
+28%
|
|
Pre-Tax Income | ||||||||||||||||||||||||||||||||||||||
Interest Income Expense |
(3)
|
(3)
|
(2)
|
(2)
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
2
|
2
|
2
|
2
|
2
|
2
|
2
|
1
|
1
|
1
|
0
|
0
|
0
|
0
|
(0)
|
0
|
0
|
1
|
1
|
1
|
2
|
2
|
|
Non-Reccuring Items |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
3
|
4
|
6
|
6
|
6
|
8
|
0
|
0
|
(12)
|
(14)
|
|
Total Other Income |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
(1)
|
(3)
|
(2)
|
(3)
|
(0)
|
2
|
2
|
3
|
1
|
0
|
(0)
|
0
|
(0)
|
(2)
|
(4)
|
(3)
|
(2)
|
0
|
2
|
2
|
2
|
2
|
1
|
3
|
4
|
4
|
3
|
|
Pre-Tax Income |
(10)
N/A
|
(13)
-30%
|
(13)
-5%
|
(15)
-14%
|
(14)
+9%
|
(14)
-3%
|
(17)
-16%
|
(19)
-14%
|
(23)
-19%
|
(26)
-17%
|
(30)
-13%
|
(31)
-2%
|
(17)
+46%
|
(17)
-4%
|
(8)
+52%
|
(8)
+9%
|
(27)
-257%
|
(29)
-6%
|
(40)
-40%
|
(37)
+9%
|
(25)
+30%
|
(19)
+27%
|
(12)
+36%
|
(24)
-98%
|
(37)
-57%
|
(38)
-2%
|
(48)
-28%
|
(50)
-5%
|
(46)
+9%
|
(47)
-2%
|
(42)
+11%
|
(35)
+16%
|
(33)
+4%
|
(41)
-24%
|
(27)
+35%
|
(28)
-4%
|
(25)
+13%
|
|
Net Income | ||||||||||||||||||||||||||||||||||||||
Tax Provision |
0
|
0
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(1)
|
(1)
|
(1)
|
(1)
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Income from Continuing Operations |
(10)
|
(13)
|
(13)
|
(15)
|
(14)
|
(15)
|
(17)
|
(19)
|
(23)
|
(27)
|
(31)
|
(32)
|
(18)
|
(18)
|
(8)
|
(8)
|
(27)
|
(28)
|
(40)
|
(36)
|
(25)
|
(19)
|
(12)
|
(24)
|
(37)
|
(38)
|
(48)
|
(51)
|
(46)
|
(47)
|
(42)
|
(35)
|
(33)
|
(41)
|
(27)
|
(28)
|
(25)
|
|
Net Income (Common) |
(10)
N/A
|
(13)
-30%
|
(13)
-5%
|
(15)
-14%
|
(14)
+8%
|
(15)
-3%
|
(17)
-16%
|
(19)
-14%
|
(23)
-19%
|
(27)
-17%
|
(31)
-16%
|
(32)
-3%
|
(18)
+44%
|
(18)
-4%
|
(8)
+54%
|
(8)
+11%
|
(27)
-253%
|
(28)
-6%
|
(40)
-41%
|
(36)
+9%
|
(28)
+22%
|
(22)
+24%
|
(15)
+32%
|
(26)
-79%
|
(37)
-41%
|
(38)
-2%
|
(48)
-28%
|
(51)
-5%
|
(46)
+10%
|
(47)
-2%
|
(42)
+11%
|
(35)
+16%
|
(33)
+4%
|
(41)
-24%
|
(27)
+35%
|
(28)
-4%
|
(25)
+13%
|
|
EPS (Diluted) |
-0.34
N/A
|
-0.44
-29%
|
-0.45
-2%
|
-0.39
+13%
|
-0.41
-5%
|
-0.36
+12%
|
-0.41
-14%
|
-0.45
-10%
|
-0.55
-22%
|
-0.62
-13%
|
-0.71
-15%
|
-0.73
-3%
|
-0.4
+45%
|
-0.36
+10%
|
-0.16
+56%
|
-0.13
+19%
|
-0.5
-285%
|
-0.55
-10%
|
-0.81
-47%
|
-0.73
+10%
|
-0.56
+23%
|
-0.39
+30%
|
-0.28
+28%
|
-0.49
-75%
|
-0.68
-39%
|
-0.68
N/A
|
-0.78
-15%
|
-0.74
+5%
|
-0.71
+4%
|
-0.63
+11%
|
-0.55
+13%
|
-0.47
+15%
|
-0.45
+4%
|
-0.56
-24%
|
-0.3
+46%
|
-0.28
+7%
|
-21.8
-7 686%
|